Effect of the compulsory license on the public provision of the announced medicine in Thailand

by Suthira Taychakhoonavudh
Published 2012

Effect of the compulsory license on the public provision of the announced medicine in Thailand

by Suthira Taychakhoonavudh
Published 2009

Revisit Roles of HTA on Drug Policy in Universal Health Coverage in Thailand: Where Are We? And What Is Next?

by Pimwara Tanvejsilp, Suthira Taychakhoonavudh, Usa Chaikledkaew, Nathorn Chaiyakunapruk, Surachat Ngorsuraches
Published 2020

Potential changes in vaccine access and policy landscape in Thailand post COVID-19 pandemic

by Warittakorn Kategeaw, Sitaporn Youngkong, Suthira Taychakhoonavudh, Sirirat Techathawat, Nathorn Chaiyakunapruk
Published 2022

Healthcare Resource Utilization and Healthcare Costs of COVID-19 Patients in A Tertiary Care Public Hospital: A Retrospective Cohort Study in Thailand

by Jirapong Leeyaphan, Charussri Leeyaphan, Patama Suttha, Suthira Taychakhoonavudh, Nattanichcha Kulthanachairojana
Published 2022

Home-based chemotherapy for stage III colon cancer patients in Thailand: Cost-utility and budget impact analyses

by Nattanichcha Kulthanachairojana, Phichai Chansriwong, Nintita Sripaiboonkij Thokanit, Suwannee Sirilerttrakul, Nopakan Wannakansophon, Suthira Taychakhoonavudh
Published 2021

Cost-effectiveness analysis and safety of erythromycin 4% gel and 4% chlorhexidine scrub for pitted keratolysis treatment

by Charussri Leeyaphan, Sumanas Bunyaratavej, Suthira Taychakhoonavudh, Nattanichcha Kulthanachairojana, Penvadee Pattanaprichakul, Pattriya Chanyachailert, Punyawee Ongsri, Sittiroj Arunkajohnsak, Pichaya Limphoka, Kanokvalai Kulthanan
Published 2020

Preclinical evaluation of a plant-derived SARS-CoV-2 subunit vaccine: Protective efficacy, immunogenicity, safety, and toxicity

by Balamurugan Shanmugaraj, Narach Khorattanakulchai, Chalisa Panapitakkul, Ashwini Malla, Rawiwan Im-erbsin, Manutsanun Inthawong, Piyanate Sunyakumthorn, Taweewun Hunsawong, Chonticha Klungthong, Matthew C. Reed, Taratorn Kemthong, Nutchanat Suttisan, Suchinda Malaivijitnond, Passaraporn Srimangkornkaew, Aekkarin Klinkhamhom, Suwimon Manopwisedjaroen, Arunee Thitithanyanont, Suthira Taychakhoonavudh, Waranyoo Phoolcharoen
Published 2022

Situation of snakebite, antivenom market and access to antivenoms in ASEAN countries

by Chanthawat Patikorn, Ahmad Khaldun Ismail, Syafiq Asnawi Zainal Abidin, Francis Bonn Blanco, Jörg Blessmann, Khamla Choumlivong, John David Comandante, Uyen Vy Doan, Zainalabidin Mohamed Ismail, Yi Yi Khine, Tri Maharani, Myat Thet Nwe, Reza Murad Qamruddin, Ruth Sabrina Safferi, Emelia Santamaria, Patrick Joseph G. Tiglao, Satariya Trakulsrichai, Taksa Vasaruchapong, Nathorn Chaiyakunapruk, Suthira Taychakhoonavudh, Iekhsan Othman
Published 2022

Cost-effectiveness analysis of pembrolizumab in high-risk early-stage triple-negative breast cancer in Thailand

by Thanapol Khuharatanachai
Published 2024

Economic burden of snakebite and cost-effectiveness of improving access to snake antivenom in Asean countries

by Chanthawat Patikorn
Published 2022

Antivenom cross-neutralization and neutralization: a systematic review of non-clinical studies in Asia region

by Sutinee Soopairin
Published 2021

Impact of maximum prescription length supply policy on patient medication adherence, health and economic outcomes

by Inthorn Jarujumrus
Published 2020